US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 245.440
  • +0.180+0.07%
Close Dec 13 16:00 ET
  • 246.570
  • +1.130+0.46%
Post 20:01 ET
31.66BMarket Cap-93.68P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Alnylam Pharmaceuticals Q3 2024 Earnings Date

Currency:USDOct 31, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
527.02M
500.92M
-26.10M
Miss Est.
-29.78%
-33.26%
-4.95%
EPS
-0.94
-0.87
+0.07
Beat Est.
-179.88%
-175.65%
+7.70%
Buy

Dec 13, 2024

Alnylam Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 558.351M--
--2024/Q4-- / 579.267M--
Oct 31, 20242024/Q3500.919M / 527.024M--
Aug 1, 20242024/Q2659.825M / 444.155M--
May 2, 20242024/Q1494.333M / 426.730M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 558.351M--
--2024/Q4-- / 579.267M--
Oct 31, 20242024/Q3500.919M / 527.024M--
Aug 1, 20242024/Q2659.825M / 444.155M--
May 2, 20242024/Q1494.333M / 426.730M--

Unlock Free Earnings Estimates

Alnylam Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Dec 13, 2024

Buy

  • Buy

    76.19%
  • Hold

    19.05%
  • Sell

    4.76%

Price Target

No Data

Heat List
US
Overall
Symbol
Price
% Chg

No Data